| Literature DB >> 12771983 |
J Li1, C Johansen, J Olsen.
Abstract
Psychological stress has been suggested to shorten cancer survival, but few studies have examined the effect of parental bereavement, and the results have been inconsistent. We identified all 21 062 parents who lost a child in Denmark from 1980 to 1996 and among them, 1630 parents with subsequent incident cancer formed the exposed cohort. We recruited 6237 incident cancer patients from a group of 293 745 randomly selected unexposed parents matched on family structure at the same time as the bereaved parents. All incident cancers in the two cohorts were followed to the end of 1997, or until they died. Cox proportional-hazards regression models were used to evaluate the hazard ratio (HR) of dying in exposed parents with cancer. The overall HR of dying from an incident cancer in exposed parents was 1.23 (95% confidence interval 1.03-1.47) compared to parents with cancer who did not lose a child. The HRs were nearly identical to those in the unexposed parents for site-specific cancers like lung cancer, breast cancer, and other groups of cancers like cancers in all digestive organs, smoking-related cancers, alcohol-related cancers, hormone-related cancers, virus/immune-related cancers, and lymphatic/haematopoietic cancers. Death of a child is not a strong prognostic factor for cancer survival among parents diagnosed with cancer after the bereavement. However, a small impairment in overall cancer survival cannot be ruled out.Entities:
Mesh:
Year: 2003 PMID: 12771983 PMCID: PMC2377144 DOI: 10.1038/sj.bjc.6600948
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640
Hazard ratio (HRs) of dying in bereaved cancer parents grouped by the time from recruitment to cancer diagnosis, Denmark 1980-1997
| All | 1.23 (1.03–1.47) | 1.26 (0.98–1.63) | 1.19 (0.93–1.52) |
| 0–4 years | 1.15 (0.79–1.69) | 1.59 (0.89–2.85) | 0.93 (0.56–1.57) |
| 5–8 years | 1.28 (0.92–1.77) | 1.32 (0.82–2.12) | 1.26 (0.81–1.99) |
| 9–12 years | 1.31 (0.93–1.85) | 1.16 (0.67–2.01) | 1.45 (0.93–2.25) |
| >12 years | 1.15 (0.78–1.69) | 1.21 (0.76–1.95) | 1.11 (0.58–2.13) |
HR=hazard ratio adjusted for: age group, gender, school education, residence, number of children in the family, number of parents in the family
Hazard ratios (HRs) of dying in cancer parents by cancer groups, Denmark 1980–1997
| Cancer in the digestive system | 1.23 (0.85–1.78) | 0.97 (0.60–1.56) | 1.22 (0.70–2.13) |
| Cancers in the respiratory system | 0.95 (0.65–1.40) | 0.84 (0.52–1.34) | 0.92 (0.47–1.77) |
| Smoking-related cancers | 1.02 (0.74–1.40) | 0.99 (0.66–1.48) | 1.06 (0.66–1.76) |
| Alcohol-related cancers | 1.74 (0.80–3.77) | 1.99 (0.81–4.85) | 1.59 (0.30–8.41) |
| Virus/immune-related cancers | 1.08 (0.67–1.73) | 0.96 (0.46–1.98) | 0.99 (0.55–1.79) |
| Lymphatic/haematopoietic cancers | 0.86 (0.39–1.88) | 1.20 (0.47–3.09) | 0.45 (0.11–1.96) |
| Hormone-related cancers (mothers) | 1.36 (0.91–2.04) | ||
HR=hazard ratio adjusted for: age group, gender, school education, residence, number of children in the family, number of parents in the family
Smoking-related cancers=ICD 7 codes 140, 141, 143–149, 150, 157, 160–162, 180, 181; alcohol-related cancers=ICD 7 codes 141, 143–146, 148-150, 155, 161; virus/immune-related cancers=ICD 7 codes 155, 171, 191, 200–202, 204; lymphatic/haematopoietic cancers=ICD 7 codes 200–205; hormone-related cancers=ICD 7 codes 170, 172, 175, 177.
Hazard ratios (HRs) of dying in parents for specific cancers grouped according to, a priori, expected 5-year survivalb: Cox regression
| 81/849 | 54/596 | 0.96 (0.73–1.28) | |
| Oesophagus | 5/36 | 5/22 | 1.22 (0.33–4.51) |
| Gall bladder | 3/22 | 3/12 | 1.54 (0.18–12.93) |
| Stomach | 10/101 | 8/65 | 1.42 (0.65–3.09) |
| Lung cancer | 46/487 | 29/354 | 0.85 (0.57–1.25) |
| Acute leukaemia | 9/69 | 3/41 | 0.59 (0.13–2.63) |
| Pancreas | 8/100 | 6/79 | 1.92 (0.75–4.89) |
| 183/2519 | 45/548 | 1.29 (0.93–1.72) | |
| Breast (mothers) | 99/1380 | 20/244 | 1.40 (0.89–2.22) |
| Bone and soft tissue | 5/58 | 1/12 | 0.33 (0.02–6.24) |
| Colon/rectum | 21/253 | 6/90 | 0.89 (0.38–2.08) |
| Ovary (mothers) | 12/173 | 6/67 | 1.76 (0.72–4.29) |
| Cervix (mothers) | 36/477 | 7/63 | 1.33 (0.60–2.95) |
| Prostate (fathers) | 5/111 | 2/57 | 4.99 (0.72–34.76) |
| 221/3122 | 36/486 | 1.19 (0.84–1.67) |
HR: hazard ratio adjusted for: age group, gender, school education, residence, number of children in the family, number of parents in the family.
Expected 5-year survival: specific cancers grouped according to the grouping in The EUROCARE-2 Study, 1985–89 for aged 15–44 years as following: <40% (hypopharynx, oesophagus, liver, gall bladder, pancreas, lung, pleura, stomach, acute leukaemia); 40–75% (colon/rectum, cervix, bone and soft tissue, ovary, prostate, larynx, breast, brain, kidney); other cancers not included in the above two groups.